Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder

MC Christensen, RS McIntyre, M Adair, I Florea… - CNS …, 2023 - cambridge.org
BackgroundVortioxetine has demonstrated dose-dependent efficacy in patients with major
depressive disorder (MDD), with the greatest effect observed with vortioxetine 20 mg/day …
被引用次数：5 相关文章
[PDF] archive.org

[PDF][PDF] Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder

MC Christensen, RS McIntyre, M Adair, I Florea, H Loft… - 2023 - scholar.archive.org
Background. Vortioxetine has demonstrated dose-dependent efficacy in patients with major
depressive disorder (MDD), with the greatest effect observed with vortioxetine 20 mg/day …

Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder

MC Christensen, RS McIntyre, M Adair… - CNS …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Vortioxetine has demonstrated dose-dependent efficacy in patients with major
depressive disorder (MDD), with the greatest effect observed with vortioxetine 20 mg/day …

[引用][C] Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder.

MC Christensen, RS McIntyre, M Adair, I Florea… - CNS …, 2023 - europepmc.org

Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder

MC Christensen, RS McIntyre, M Adair, I Florea, H Loft… - 2023 - cambridge.org
Background. Vortioxetine has demonstrated dose-dependent efficacy in patients with major
depressive disorder (MDD), with the greatest effect observed with vortioxetine 20 mg/day …

Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder

MC Christensen, RS Mcintyre, M Adair, I Florea… - CNS …, 2023 - usiena-air.unisi.it
Background: Vortioxetine has demonstrated dose-dependent efficacy in patients with major
depressive disorder (MDD), with the greatest effect observed with vortioxetine 20 mg/day …
[PDF] unisi.it

[PDF][PDF] Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder

MC Christensen, RS McIntyre, M Adair, I Florea, H Loft… - 2023 - usiena-air.unisi.it
Background. Vortioxetine has demonstrated dose-dependent efficacy in patients with major
depressive disorder (MDD), with the greatest effect observed with vortioxetine 20 mg/day …